The actual controller of REMEGEN (688331.SH) completed the acquisition of 369,200 shares through the controlled enterprise.
Rongchang Biology (688331.SH) announced that from July 9, 2024 to January 8, 2025, the company...
REMEGEN (688331.SH) announced that from July 9, 2024 to January 8, 2025, the actual controllers of the company, including Wang Weidong, Fang Jianmin, Lin Jian, Wang Liqiang, Wang Xudong, Deng Yong, Xiong Xiaobin, Yang Minhua, Wen Qingkai, and Wei Jianliang, through their controlled enterprise Yantai Rongchang Holdings Group Co., Ltd., increased their holdings of the company's shares by a total of 369,200 shares through the Shanghai Stock Exchange trading system through centralized competitive bidding, accounting for 0.0678% of the company's total share capital, with a total increase amount of RMB 10,000,000.646 (excluding transaction costs), which has exceeded the lower limit of the current shareholding increase plan. The shareholding increase plan has been completed.
Related Articles

Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.

US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.

Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families






